SLC5A2 and hydrops fetalis: However, during our study period from 2009 to 2012, SGLT-2 inhibitor was not released and the use of GLP-RA was almost insignificant in Korea [53], therefore we could not evaluate the effects of these drugs on HF and CV mortality.